Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial.
Zhang T, Howard L, Koontz BF, Tagawa ST, Nagar H, Bitting RL, Frizzell BA, Nordquist L, Rasmussen J, Riggan C, Reyes M, Davies C, Gray SR, Newman CR, Fernandez E, Ramalingam S, Harrison MR, George DJ, Wu Y, Armstrong AJ.
Zhang T, et al. Among authors: newman cr.
Eur Urol Oncol. 2024 Jul 5:S2588-9311(24)00160-3. doi: 10.1016/j.euo.2024.06.013. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38971644